title: Correlation of QTc interval prolongation and serum level of citalopram after intoxication--a case report.
abstract: Citalopram (CIT) is a widely used antidepressant which acts by a selective serotonin reuptake inhibition. It is considered to be safer than tricyclic antidepressants at therapeutic levels, but also with respect to intoxications. We report the case of a 46-year-old woman, who ingested in suicidal intention 1400 mg CIT. During the following inpatient treatment repeatedly ECGs and determinations of the serum level of CIT were performed. Initially the patient's serum level of CIT was 1231 ng/mL and QTc interval was 541.60 ms. It took 12 days until the serum level of CIT fell below the upper threshold of the recommended therapeutic range (130 ng/mL). The QTc interval on the sixth day after the intoxication for the first time was below 500 ms. The QTc interval correlated significantly with the serum level of CIT after intoxication (r=0.943; p<0.005). Although CIT is estimated as a safe antidepressant regarding serious adverse effects, toxic doses can lead to potentially hazardous ECG changes which according to our findings correlate strongly with the serum level of the drug.
authors: S
authors: S
authors: Unterecker
authors: B
authors: B
authors: Warrings
authors: J
authors: J
authors: Deckert
authors: B
authors: B
authors: Pfuhlmann
mesh_terms: D000928:Antidepressive Agents / Q000097:blood* / Q000493:pharmacokinetics / Q000506:poisoning; D015283:Citalopram / Q000097:blood* / Q000493:pharmacokinetics / Q000506:poisoning*; D003865:Major Depressive Disorder / Q000097:blood* / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced*; D008875:Middle Aged; D017367:Selective Serotonin Reuptake Inhibitors / Q000097:blood* / Q000493:pharmacokinetics / Q000506:poisoning; D013406:Suicide, Attempted; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors